Evinacumab Reduces Lipids, Cholesterol in Hypercholsterolemia and Hypertriglyceridemia; Data from a meta-analysis of evinacumab trials reveal significant reductions in cholesterol and other lipid markers among patients with dyslipidemia.

Press/Media

Period16 May 2024

Media coverage

2

Media coverage

  • TitleEvinacumab Reduces Lipids, Cholesterol in Hypercholsterolemia and Hypertriglyceridemia; Data from a meta-analysis of evinacumab trials reveal significant reductions in cholesterol and other lipid markers among patients with dyslipidemia.
    Media name/outletConsultant Live
    Country/TerritoryUnited States
    Date16/05/24
    PersonsRobert Sidney Rosenson
  • TitleEvinacumab Reduces Lipids, Cholesterol in Hypercholsterolemia and Hypertriglyceridemia
    Media name/outletHCP Live
    Country/TerritoryUnited States
    Date16/05/24
    PersonsRobert Sidney Rosenson